Global Anti-Peptic Ulcer Drugs Market Research Report 2020

Published On: Jan 2020

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 89697


The global Anti-Peptic Ulcer Drugs market is valued at 6720.5 million US$ in 2020 is expected to reach 16340 million US$ by the end of 2026, growing at a CAGR of 13.4% during 2021-2026.
This report focuses on Anti-Peptic Ulcer Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anti-Peptic Ulcer Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Anti-Peptic Ulcer Drugs market is segmented into
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs

Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)

Global Anti-Peptic Ulcer Drugs Market: Regional Analysis
The Anti-Peptic Ulcer Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Anti-Peptic Ulcer Drugs market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Anti-Peptic Ulcer Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Anti-Peptic Ulcer Drugs market include:
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen

Table of Contents

1 Anti-Peptic Ulcer Drugs Market Overview
1.1 Product Overview and Scope of Anti-Peptic Ulcer Drugs
1.2 Anti-Peptic Ulcer Drugs Segment by Type
1.2.1 Global Anti-Peptic Ulcer Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Ulcer Protective Drugs
1.3 Anti-Peptic Ulcer Drugs Segment by Application
1.3.1 Anti-Peptic Ulcer Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Global Anti-Peptic Ulcer Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Peptic Ulcer Drugs Revenue 2015-2026
1.4.2 Global Anti-Peptic Ulcer Drugs Sales 2015-2026
1.4.3 Anti-Peptic Ulcer Drugs Market Size by Region: 2020 Versus 2026

2 Global Anti-Peptic Ulcer Drugs Market Competition by Manufacturers
2.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Peptic Ulcer Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Peptic Ulcer Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Peptic Ulcer Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anti-Peptic Ulcer Drugs Market Competitive Situation and Trends
2.5.1 Anti-Peptic Ulcer Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Peptic Ulcer Drugs Players (Opinion Leaders)

3 Anti-Peptic Ulcer Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Peptic Ulcer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Peptic Ulcer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Peptic Ulcer Drugs Market Facts & Figures by Country
3.3.1 North America Anti-Peptic Ulcer Drugs Sales by Country
3.3.2 North America Anti-Peptic Ulcer Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Peptic Ulcer Drugs Market Facts & Figures by Country
3.4.1 Europe Anti-Peptic Ulcer Drugs Sales by Country
3.4.2 Europe Anti-Peptic Ulcer Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Peptic Ulcer Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Peptic Ulcer Drugs Sales by Region
3.5.2 Asia Pacific Anti-Peptic Ulcer Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Peptic Ulcer Drugs Market Facts & Figures by Country
3.6.1 Latin America Anti-Peptic Ulcer Drugs Sales by Country
3.6.2 Latin America Anti-Peptic Ulcer Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Peptic Ulcer Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Country
3.7.2 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Peptic Ulcer Drugs Historic Market Analysis by Type
4.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
4.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Peptic Ulcer Drugs Price Market Share by Type (2015-2020)
4.4 Global Anti-Peptic Ulcer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Anti-Peptic Ulcer Drugs Historic Market Analysis by Application
5.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
5.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Peptic Ulcer Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Anti-Peptic Ulcer Drugs Business
6.1 AstraZeneca
6.1.1 Corporation Information
6.1.2 AstraZeneca Description, Business Overview and Total Revenue
6.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AstraZeneca Products Offered
6.1.5 AstraZeneca Recent Development
6.2 Ask-pharm
6.2.1 Ask-pharm Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.2.2 Ask-pharm Description, Business Overview and Total Revenue
6.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Ask-pharm Products Offered
6.2.5 Ask-pharm Recent Development
6.3 Takeda
6.3.1 Takeda Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.3.2 Takeda Description, Business Overview and Total Revenue
6.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Takeda Products Offered
6.3.5 Takeda Recent Development
6.4 Yangtze River Pharm
6.4.1 Yangtze River Pharm Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.4.2 Yangtze River Pharm Description, Business Overview and Total Revenue
6.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Yangtze River Pharm Products Offered
6.4.5 Yangtze River Pharm Recent Development
6.5 Shandong Luoxin
6.5.1 Shandong Luoxin Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.5.2 Shandong Luoxin Description, Business Overview and Total Revenue
6.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Shandong Luoxin Products Offered
6.5.5 Shandong Luoxin Recent Development
6.6 Huadong Medicine
6.6.1 Huadong Medicine Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.6.2 Huadong Medicine Description, Business Overview and Total Revenue
6.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Huadong Medicine Products Offered
6.6.5 Huadong Medicine Recent Development
6.7 Changzhou Siyao
6.6.1 Changzhou Siyao Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.6.2 Changzhou Siyao Description, Business Overview and Total Revenue
6.6.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Changzhou Siyao Products Offered
6.7.5 Changzhou Siyao Recent Development
6.8 Beijing Yuekang
6.8.1 Beijing Yuekang Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.8.2 Beijing Yuekang Description, Business Overview and Total Revenue
6.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Beijing Yuekang Products Offered
6.8.5 Beijing Yuekang Recent Development
6.9 Guangdong Dahua
6.9.1 Guangdong Dahua Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.9.2 Guangdong Dahua Description, Business Overview and Total Revenue
6.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Guangdong Dahua Products Offered
6.9.5 Guangdong Dahua Recent Development
6.10 Xian Janssen
6.10.1 Xian Janssen Anti-Peptic Ulcer Drugs Production Sites and Area Served
6.10.2 Xian Janssen Description, Business Overview and Total Revenue
6.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Xian Janssen Products Offered
6.10.5 Xian Janssen Recent Development

7 Anti-Peptic Ulcer Drugs Manufacturing Cost Analysis
7.1 Anti-Peptic Ulcer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Peptic Ulcer Drugs
7.4 Anti-Peptic Ulcer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Peptic Ulcer Drugs Distributors List
8.3 Anti-Peptic Ulcer Drugs Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Anti-Peptic Ulcer Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Peptic Ulcer Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Peptic Ulcer Drugs by Type (2021-2026)
10.2 Anti-Peptic Ulcer Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Peptic Ulcer Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Peptic Ulcer Drugs by Application (2021-2026)
10.3 Anti-Peptic Ulcer Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Peptic Ulcer Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Peptic Ulcer Drugs by Region (2021-2026)
10.4 North America Anti-Peptic Ulcer Drugs Estimates and Projections (2021-2026)
10.5 Europe Anti-Peptic Ulcer Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Peptic Ulcer Drugs Estimates and Projections (2021-2026)
10.7 Latin America Anti-Peptic Ulcer Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Peptic Ulcer Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer